Comparing the Efficacy of Steroid, Acupuncture and Platelet Rich Plasma Injection in Patients with Sciatica

NCT ID: NCT03801512

Last Updated: 2024-12-05

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 90 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-04-24
• Study Completion Date: 2025-05-28

Brief Summary

Disc herniation, stenosis of the spine and spondylolisthesis are the common causes of radiculitis in medical practice today, and can cause symptoms of sciatica. Steroid injection, acupuncture and platelet-rich plasma injection are often used interventions for the treatments of sciatica. The investigators will investigate the efficacy and safety of steroid injection, acupuncture and platelet-rich plasma injection for sciatica in this single center, parallel, randomized-controlled clinical trial.

Detailed Description

Steroid injection, acupuncture and platelet-rich plasma injection are often used interventions for the treatments of sciatica. The investigators will investigate the efficacy and safety of steroid injection, acupuncture and platelet-rich plasma injection for sciatica in this single center, parallel, randomized-controlled clinical trial.

Participants will be randomized into 3 groups (steroid injection, acupuncture and platelet-rich plasma injection) by central allocation. Randomized participants will complete a questionnaire that solicited information regarding age, sex, marital status, occupation, education, and medical history. The blinding credibility of the treatments will be evaluated at the end of the treatment.

Participants in steroid injection group will receive Triamcinolone 1pc plus lidocaine 1% 1cc injection at neuritis nerve roots. Participants in platelet-rich plasma injection group will receive 15cc blood draw first to concentrate into platelet-rich plasma and then inject at neuritis nerve roots. Participants in acupuncture group received standardized acupuncture treatment. hat treatment was accomplished by selecting a group of acupuncture points that predefined. Acupuncture points will be bladder meridian pattern acupuncture points including Shenshu (BL23), Qihaishu (BL24), Dachangshu (BL25), and Guanyuanshu(BL26). The needles will be inserted perpendicular to a depth of 5 to 35 mm depending on the acupuncture point, which was followed by manual stimulation by bidirectional rotation to induce Deqi sensation. Deqi was defined as a dull, localized, and aching sensation, which signaled the attainment of qi.

Outcome Measures Primary Outcome Measure The primary outcome measure is visual analogue scale for sciatica. To understand the impact of sciatica on the participants' life, visual analogue scale for bothersomeness is chosen instead of pain intensity. The participants will be asked to mark, on a 10 cm visual analogue scale (0, absence of bothersomeness; 10, the worst bothersomeness imaginable), the average degree of bothersomeness due to sciatica experienced within the most recent 1 week from the day of the assessment. This measurement has substantial validity. Bothersomeness of sciatica will be measured at baseline, 1-, 2-, 4-, 8-, 12-, 16-, and 24-week.

Secondary Outcome Measures Numeric Rating Scale for pain intensity is a simple method evaluating the subjective intensity of pain. Pain intensity will be measured in the same way as visual analogue scale for bothersomeness. Validity of its reliability has been demonstrated. The Chinese version Oswestry Disability Index is used to measure back pain-related dysfunction. Health-related quality of life will be measured using the well-validated EuroQol 5 dimensions (EQ-5D). A higher score is indicative of a better general health status. Participants satisfaction will be evaluated with 5 point scale (1 is worst, and 5 is best)

We will perform the Shapiro-Wilk normality test to determine whether or not the sample values followed a normal distribution and finally assumed normality according to the test result. For the description of baseline characteristics, mean with standard deviation (SD) for continuous data and frequency with percentage for dichotomous data will be described. Also, for the homogeneity test of baseline characteristics between 3 groups, 2-sample t tests for continuous data and chi-square test for dichotomous data will be performed. A mixed-model approach of repeated-measures 2-factor analysis will be used to analyze the difference and mean change in baseline, 1-, 2-, 4-, 8-, 12-, 16-, and 24-week visual analogue scale score, Oswestry Disability Index, EQ-5D, patient satisfaction difference and mean change between groups, interaction between groups, and periods.

Conditions

Sciatica

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Steroid Injections

Inject steroid at neuritis nerve root.

Group Type: EXPERIMENTAL

Steroid

Intervention Type: OTHER

Triamcinolone 1pc + lidocaine 1% 1cc inject at neuritis nerve roots

Acupuncture

Acupuncture at acupoints BL23 to BL26.

Group Type: EXPERIMENTAL

Acupuncture

Intervention Type: OTHER

1.5 inch acupuncture needles insert at acupoints BL23, BL24, BL25 and BL26

Platelet Rich Plasma Injection

Inject Platelet Rich Plasma at neuritis nerve root.

Group Type: EXPERIMENTAL

Platelet Rich Plasma

Intervention Type: OTHER

Inject investigators Platelet Rich Plasma at neuritis nerve roots

Interventions

Steroid

Triamcinolone 1pc + lidocaine 1% 1cc inject at neuritis nerve roots

Intervention Type: OTHER

Acupuncture

1.5 inch acupuncture needles insert at acupoints BL23, BL24, BL25 and BL26

Intervention Type: OTHER

Platelet Rich Plasma

Inject investigators Platelet Rich Plasma at neuritis nerve roots

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Female or male, 20 to 80 years of age.

2. Participants who had dermatome between L3 to S1, or participants whose straight leg raising test was positive, or participants had Meyerding Grade I to II spondylolisthesis or herniated intervertebral disc or spinal stenosis diagnosed by X-rays, Magnetic resonance imaging or computed tomography.

3. Participants whose sciatica symptom doesn't have occur time limit.

4. Participants who agreed to follow the trial protocol.

5. Participants who could complete the study treatment and assessments.

6. Participants who had steroid or pain control injection can participate the study after receiving injection more than 3 days.

Exclusion Criteria

1. Participants with severe progressive neurological symptoms (e.g. cauda equina compression).

2. Participants who had undergone surgery for lumbar disc herniation within 6 months.

3. Participants whose sciatica symptom wasn't caused by lumbar radiculopathy.

4. Participants with cardiovascular, liver, kidney, or hematopoietic system diseases, severe psychiatric or psychological disorder, or cancer.

5. Women who were pregnant.

6. Participants with a pacemaker, metal allergy, or severe fear of needles.

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Taipei Medical University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Meng-Huang Wu

Attending physician, Department of Orthopedics

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Ray-Jade Chen, PhD

Role: STUDY_CHAIR

Taipei Medical University Hospital

Locations

Taipei Medical University Hospital

Taipei, Taiwan, Taiwan

Site Status: RECRUITING

Countries

Taiwan

Central Contacts

Meng-Huang Wu, PhD

Role: CONTACT

Phone: 886 2 27372181

Email: 141036@h.tmu.edu.tw

Ray-Jade Chen, PhD

Role: CONTACT

Facility Contacts

Meng-Huang Wu

Role: primary

References

Inoue M, Hojo T, Yano T, Katsumi Y. Electroacupuncture direct to spinal nerves as an alternative to selective spinal nerve block in patients with radicular sciatica--a cohort study. Acupunct Med. 2005 Mar;23(1):27-30. doi: 10.1136/aim.23.1.27.

Reference Type: BACKGROUND

PMID: 15844437 (View on PubMed)

Abbasipour-Dalivand S, Mohammadi R, Mohammadi V. Effects of Local Administration of Platelet Rich Plasma on Functional Recovery after Bridging Sciatic Nerve Defect Using Silicone Rubber Chamber; An Experimental Study. Bull Emerg Trauma. 2015 Jan;3(1):1-7.

Reference Type: BACKGROUND

PMID: 27162893 (View on PubMed)

Kucuk L, Gunay H, Erbas O, Kucuk U, Atamaz F, Coskunol E. Effects of platelet-rich plasma on nerve regeneration in a rat model. Acta Orthop Traumatol Turc. 2014;48(4):449-54. doi: 10.3944/AOTT.2014.13.0029.

Reference Type: BACKGROUND

PMID: 25230270 (View on PubMed)

Centeno C, Markle J, Dodson E, Stemper I, Hyzy M, Williams C, Freeman M. The use of lumbar epidural injection of platelet lysate for treatment of radicular pain. J Exp Orthop. 2017 Nov 25;4(1):38. doi: 10.1186/s40634-017-0113-5.

Reference Type: BACKGROUND

PMID: 29177632 (View on PubMed)

Other Identifiers

N201805024

Identifier Type: -

Identifier Source: org_study_id